Docosahexaenoic Acid Induces Growth Suppression on Epithelial Ovarian Cancer Cells More Effectively than Eicosapentaenoic Acid

References

• Bougnoux P, Hajjaji N, Maheo K, Couet C, and Chevalier S: Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth. Prog Lipid Res 49, 76–86, 2010.
   PubMed Web of Science ®Google Scholar
• Chapkin RS, Seo J, McMurray DN, and Lupton JR: Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine. Chem Phys Lipids 153, 14–23, 2008.
   PubMed Web of Science ®Google Scholar
• Cockbain AJ, Toogood GJ, and Hull MA: Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer. Gut 61, 135–149, 2012.
   PubMed Web of Science ®Google Scholar
• Leitzmann MF, Stampfer MJ, Michaud DS, Augustsson K, Colditz GC, et al.: Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr 80, 204–216, 2004.
   PubMed Web of Science ®Google Scholar
• Song KS, Jing K, Kim JS, Yun EJ, Shin S, et al. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling. Pancreatology 11, 574–584, 2011.
   PubMed Web of Science ®Google Scholar
• Allred CD, Talbert DR, Southard RC, Wang X, and Kilgore MW: PPAR gamma 1 as a molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells. J Nutr 138, 250–256, 2008.
   PubMed Web of Science ®Google Scholar
• Bonofiglio D, Aquila S, Catalano S, Gabriele S, Belmonte M, et al.: Peroxisome proliferator-activated receptor-gamma activates p53 gene promoter binding to the nuclear factor-kappa B sequence in human MCF7 breast cancer cells. Mol Endocrinol 20, 3083–3092, 2006.
   PubMed Web of Science ®Google Scholar
• Schley PD, Jijon HB, Robinson LE, and Field CJ: Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Res Tr 92, 187–195, 2005.
   PubMed Web of Science ®Google Scholar
• Edwards IJ and O'Flaherty JT: Omega-3 fatty acids and PPARγ in cancer. PPAR Res 2008, 350852, 2008.
   Web of Science ®Google Scholar
• Sun H, Berquin IM, and Edwards IJ: Omega-3 polyunsaturated fatty acids regulate syndecan-1 expression in human breast cancer cells. Cancer Res 65, 4442–4447, 2005.
   PubMed Web of Science ®Google Scholar
• Sun H, Berquin IM, Owens RT, O'Flaherty JT, and Edwards IJ: Peroxisome proliferator-activated receptor γ;-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells. Cancer Res 68, 2912–2919, 2008.
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, et al.: The nuclear receptor superfamily: The second decade. Cell 83, 835–839, 1995.
   PubMed Web of Science ®Google Scholar
• Qi C, Zhu Y, and Reddy JK: Peroxisome proliferator-activated receptors, coactivators, and downstream targets. Cell Biochem Biophys 32, 187–204, 2000.
   PubMed Web of Science ®Google Scholar
• Li CC, Hou YC, Yeh CL, and Yeh SL: Effects of eicosapentaenoic acid and docosahexaenoic acid on prostate cancer cell migration and invasion induced by tumor-associated macrophages. PLoS ONE 9, e99630, 2014.
   PubMed Web of Science ®Google Scholar
• Park BH, Lee SB, Stolz DB, Lee YJ, and Lee BC: Synergistic interactions between heregulin and peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonist in breast cancer cells. J Biol Chem 286, 20087–20099, 2011.
   PubMed Web of Science ®Google Scholar
• Yang YC, Tsao YP, Ho TC, and Choung IP: Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines. Int J Gynecol Cancer 17, 418–425, 2007.
   PubMed Web of Science ®Google Scholar
• Schuler M and Green DR: Mechanisms of p53-dependent apoptosis. Biochem Soc T 29, 684–688, 2001.
   PubMed Web of Science ®Google Scholar
• Bidoli E, La Vecchi C, Montella M, Maso LD, Conti E, et al.: Nutrient intake and ovarian cancer: an Italian case-control study. Cancer Cause Control 13, 255–261, 2002.
   PubMed Web of Science ®Google Scholar
• Bosetti C, Negri E, Franceschi S, Pelucchi C, Talamini R, et al.: Diet and ovarian cancer risk: a case-control study in Italy. Int J Cancer 93, 911–915, 2001.
   PubMed Web of Science ®Google Scholar
• Merritt MA, Cramer DW, Missmer SA, Vitonis AF, Titus LJ, et al.: Dietary fat intake and risk of epithelial ovarian cancer by tumor histology. Bri J Cancer 110, 1392–1401, 2014.
   PubMed Web of Science ®Google Scholar
• La Vecchia C, Decarli A, Negri E, Parazzini F, Gentile A, et al.: Dietary factors and the risk of epithelial ovarian cancer. J Natl Cancer I 79, 663–669, 1987.
   PubMed Web of Science ®Google Scholar
• Tavani A, Pelucchi C, Parpinel M, Negri E, Franceschi S, et al.: n-3 polyunsaturated fatty acid intake and cancer risk in Italy and Switzerland. Int J Cancer 105, 113–116, 2003.
   PubMed Web of Science ®Google Scholar
• Sharma A, Belna J, Logan J, Espat J, and Hurteau JA: The effects of omega-3 fatty acids on growth regulation of epithelial ovarian cancer cell lines. Gynecol Oncol 99, 58–64, 2005.
   PubMed Web of Science ®Google Scholar
• Sharma A, Belna J, Espat J, Rodriguez G, Cannon VT, et al.: Effects of omega-3 fatty acids on components of the transforming growth factor beta-1 pathway: implication for dietary modification and prevention in ovarian cancer. Am J Obstet Gynecol 200, 511–516, 2009.
   Web of Science ®Google Scholar
• Leonardi F, Attorri L, Di Benedetto R, Di Biase A, Sanchez M, et al.: Effect of arachidonic, eicosapentaenoic and docosahexaenoic acids on the oxidative status of C6 glioma cells. Free Radic Res 39, 865–874, 2005.
   PubMed Web of Science ®Google Scholar
• Merendino N, Loppi B, D'Aquino M, Molinari R, Pessina G, et al.: Docosahexaenoic acid induces apoptosis in the human PaCa-44 pancreatic cancer cell line by active reduced glutathione extrusion and lipid peroxidation. Nutr Cancer 52, 225–233, 2005.
   PubMed Web of Science ®Google Scholar
• Tuller ER, Brock AL, Yu H, Lou JR, Benbrook DM, et al.: PPAR alpha signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells. Biochem Pharmacol 77, 1480–1486, 2009.
   PubMed Web of Science ®Google Scholar
• Noguchi M, Earashi M, Minami M, Kinoshita K, and Miyazaki I: Effects of eicosapentaenoic and docosahexaenoic acid on cell growth and prostaglandin E and leukotriene B production by a human breast cancer cell line (MDA-MB-231). Oncology 52, 458–464, 1995.
   PubMed Web of Science ®Google Scholar
• Falconer JS, Ross JA, Fearon KC, Hawkins RA, O'Riordain MG, et al.: Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines. Brit J Cancer 69, 826–832, 1994.
   PubMed Web of Science ®Google Scholar
• Grammatikos SI, Subbaiah PV, Victor TA, and Miller WM: n-3 and n-6 FA processing and growth effects in neoplastic and non-cancerous human mammary epithelial cell lines. Brit J Cancer 70, 219–227, 1994.
   PubMed Web of Science ®Google Scholar
• Rose DP and Connolly JM: Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. Cancer Res 50, 7139–7144, 1990.
   PubMed Web of Science ®Google Scholar
• Chamras H, Ardashian A, Heber D, and Glaspy JA: Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J Nutr Biochem 13, 711–716, 2002.
   PubMed Web of Science ®Google Scholar
• Yamamoto D, Kiyozuka Y, Adachi Y, Takada H, Hioki K, et al.: Synergistic action of apoptosis induced by eicosapentaenoic acid and TNP-470 on human breast cancer cells. Breast Cancer Res Tr 55, 149–160, 1999.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Kumlin M, Ingelman-Sundberg M, and Wolk A: Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79, 935–945, 2004.
   PubMed Web of Science ®Google Scholar
• Lee JY and Hwang DH: Docosahexaenoic acid suppresses the activity of peroxisome proliferator-activated receptors in a colon tumor cell line. Biochem Bioph Res Co 298, 667–674, 2002.
   PubMed Web of Science ®Google Scholar
• Allred CD and Kilgore MW: Selective activation of PPARγ; in breast, colon, and lung cancer cell lines. Mol Cell Endocrinol 235, 21–29, 2005.
   PubMed Web of Science ®Google Scholar
• Dikshit A, Filho MAG, Eilati E, McGee S, Small C, et al.: Flaxseed reduces the pro-carcinogenic micro-environment in the ovaries of normal hens by altering the PG and oestrogen pathways in a dose-dependent manner. Br J Nutr 113, 1384–1395, 2015.
   PubMed Web of Science ®Google Scholar
• Welsch CW: Review of the effects of dietary fat on experimental mammary gland tumorigenesis: role of lipid peroxidation. Free Radic Biol Med 18, 757–773, 1995.
   PubMed Web of Science ®Google Scholar
• Stoll BA: N-3 fatty acids and lipid peroxidation in breast cancer inhibition. Br J Nutr 87, 193–198, 2002.
   PubMed Web of Science ®Google Scholar
• Barrera G: Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol 2012, 137289:21, 2012.
   PubMedGoogle Scholar
• Xiong A, Yu W, Tiwary R, Sanders BG, and Kline K: Distinct roles of different forms of vitamin E in DHA-induced apoptosis in triple-negative breast cancer cells. Mol Nutr Food Res 56, 923–934, 2012.
   PubMed Web of Science ®Google Scholar
• Siddiqui RA, Harvey K, and Stillwell W: Anticancer properties of oxidation products of docosahexaenoic acid. Chem Phys Lipids 153, 47–56, 2008.
   PubMed Web of Science ®Google Scholar
• Nagamine M, Okumura T, Tanno S, Sawamukai M, Motomura W, et al.: PPARγ ligand-induced apoptosis through a p53-dependent mechanism in human gastric cancer cells. Cancer Sci 94, 338–343, 2003.
   PubMed Web of Science ®Google Scholar